![John W. Matthei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John W. Matthei
Personalreferent bei ATHENEXPAR
Aktive Positionen von John W. Matthei
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ATHENEXPAR | Personalreferent | 01.09.2017 | - |
Karriereverlauf von John W. Matthei
Ehemalige bekannte Positionen von John W. Matthei
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STERICYCLE, INC. | Personalreferent | 01.01.2004 | 01.01.2009 |
SAGENT PHARMACEUTICALS INC | Personalreferent | - | - |
Public Communications Contact | - | - | |
Pfingsten Partners LLC
![]() Pfingsten Partners LLC Investment ManagersFinance Pfingsten Partners LLC (Pfingsten Partners) is a private equity firm founded in 1989 by Thomas Steven Bagley. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 15.12.2009 | - |
Ausbildung von John W. Matthei
Loyola University of Chicago | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Human Resources Officer | 3 |
Private Equity Investor | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
STERICYCLE, INC. | Industrial Services |
Private Unternehmen | 3 |
---|---|
Pfingsten Partners LLC
![]() Pfingsten Partners LLC Investment ManagersFinance Pfingsten Partners LLC (Pfingsten Partners) is a private equity firm founded in 1989 by Thomas Steven Bagley. The firm is headquartered in Chicago, Illinois. | Finance |
Athenex, Inc.
![]() Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
Sagent Pharmaceuticals, Inc.
![]() Sagent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL. | Health Technology |
- Börse
- Insiders
- John W. Matthei
- Erfahrung